Friday, May 29, 2020 6:59:00 PM
Institutional ownership here has buys kinda DOW-tied. This stock dropping BELOW that 200DMA would likely have a SERIOUS DOW TEST lower!
I know, I accidentally had an order in @ $167.00 when it dropped on the 27th. I went to put an ORDER just at or slightly above the 200DMA that day & realized I had a 300 share limit order in there from the 21st that was executing.
If the stock had the KIND OF WEAKNESS you're suggesting it would have TESTED that 200DMA right then & there! And TECHNICALLY it kinda should have...
The DOW performance on this MOSTLY institutionally-owned STOCK is KEY here imv,... If the DOW stays sideways or moves higher I don't see LH taking a dive UNLESS some directly negative news event happens.
Everything is tailwind right now with CORONAVIRUS ramp-up, with country getting back to normal, with economy re-opening, travel coming back, the advances in telemed, the NEW Medable deal, etc., etc., etc..
https://finance.yahoo.com/news/labcorp-partners-medable-expand-technology-132901628.html
By next Q, there's talk LH may even GET AHEAD of U.S. corporate & announce a dividend. It'd SHOCK the market & shoot LH into the $220 range for sure imho. But even without that they should be doing well enough to see $200 test into Q3 before long. I think there's a BETTER SHOT @ a $200 test than that $120 or whatever you were hoping to buy here... I just don't see it falling that far without some SERIOUS issue or market-wide event/pressure.
Recent LH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 01:57:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/03/2026 05:23:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 03:41:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2026 02:40:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 01:25:40 PM
- Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide • PR Newswire (US) • 02/23/2026 12:00:00 PM
- Labcorp tops Q4 profit forecasts but revenue slightly misses • IH Market News • 02/17/2026 03:14:38 PM
- Labcorp Announces 2025 Fourth Quarter and Full Year Results • PR Newswire (US) • 02/17/2026 11:50:00 AM
- Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors • PR Newswire (US) • 02/09/2026 01:30:00 PM
- Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 • PR Newswire (US) • 01/15/2026 09:15:00 PM
- Labcorp Declares Quarterly Dividend • PR Newswire (US) • 01/14/2026 11:50:00 AM
- Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk • PR Newswire (US) • 01/13/2026 12:00:00 PM
- Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs • Business Wire • 01/08/2026 02:00:00 PM
- NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp • PR Newswire (US) • 01/08/2026 01:30:00 PM
- Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/30/2025 09:15:00 PM
- Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp • Business Wire • 12/02/2025 09:15:00 PM
- Labcorp Appoints Victor Bulto to Board of Directors • PR Newswire (US) • 11/24/2025 01:30:00 PM
- Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research • PR Newswire (US) • 11/19/2025 12:04:00 PM
- Labcorp Announces 2025 Third Quarter Results • PR Newswire (US) • 10/28/2025 10:50:00 AM
- Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings • PR Newswire (US) • 10/23/2025 11:00:00 AM
- Labcorp Declares Quarterly Dividend • PR Newswire (US) • 10/08/2025 08:15:00 PM
- Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities • PR Newswire (US) • 09/30/2025 11:00:00 AM
- Labcorp to Announce Third Quarter Financial Results on October 28, 2025 • PR Newswire (US) • 09/25/2025 08:15:00 PM
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses • PR Newswire (US) • 09/15/2025 12:30:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
